1. Home
  2. PCVX vs BIRK Comparison

PCVX vs BIRK Comparison

Compare PCVX & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$48.15

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo Birkenstock Holding plc

BIRK

Birkenstock Holding plc

HOLD

Current Price

$42.57

Market Cap

8.8B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCVX
BIRK
Founded
2013
1774
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
8.8B
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
PCVX
BIRK
Price
$48.15
$42.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
12
Target Price
$101.67
$65.50
AVG Volume (30 Days)
1.5M
2.8M
Earning Date
11-04-2025
12-18-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
83.10
EPS
N/A
2.19
Revenue
N/A
$2,460,904,611.00
Revenue This Year
N/A
$16.09
Revenue Next Year
N/A
$15.69
P/E Ratio
N/A
$20.02
Revenue Growth
N/A
16.22
52 Week Low
$27.66
$38.16
52 Week High
$93.77
$62.66

Technical Indicators

Market Signals
Indicator
PCVX
BIRK
Relative Strength Index (RSI) 59.46 47.70
Support Level $42.40 $40.07
Resistance Level $48.65 $44.15
Average True Range (ATR) 1.75 1.82
MACD 0.16 -0.25
Stochastic Oscillator 92.34 31.03

Price Performance

Historical Comparison
PCVX
BIRK

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About BIRK Birkenstock Holding plc

Birkenstock Holding PLC is a company that manufactures and sells footbed-based products, including sandals, closed-toe silhouettes, and other products, such as skincare and accessories, for everyday, leisure, and work. It sells its products through two main channels: business-to-business (B2B) which comprises sales made to established third-party store networks, and direct-to-consumer (DTC) which comprises sales made on globally owned online stores through the Birkenstock.com domain and sales made in Birkenstock retail stores. The company's reportable segments are based on its regional hubs and include: the Americas which is also its key revenue-generating segment; Europe; and Australia, Japan, India, China, and the United Arab Emirates (APMA).

Share on Social Networks: